LAKE OSWEGO, Ore., Sept. 22, 2014 /PRNewswire-iReach/ -- Medolac Laboratories (www.medolac.com), an Oregon-based human milk nutritionals start-up, announced today its CGI Commitment to Action at the 2014 CGI Annual Meeting. This commitment is aligned with the U.S. Surgeon General's Call to Action to Support Breastfeeding, released in 2011, which expressed grave concerns regarding critically low breastfeeding rates among African American mothers, particularly in urban centers, with the report indicating that, "breastfeeding rates for black infants are about 50 percent lower than those for white infants at birth, age six months and age 12 months..." Low breastfeeding rates for African American urban women have been a concern of health policy makers for many years considering breastfeeding's positive impact on the health and well-being for both mother and child. The company seeks to increase breastfeeding rates among urban African American Women by forming a local partnership campaign to support the growth of the Mothers Milk Cooperative's donor base, promoting healthy behavior and prolonged breastfeeding within their communities.
The Mothers Milk Cooperative (www.mothersmilk.coop), the only milk bank owned and operated by nursing mothers, will enroll at least 2,000 new urban breast milk donors, providing breastfeeding support and compensation for their qualified donor milk through coop membership. The financial impact of the program on urban African American women over three years is estimated at over $6.6 million.
This partnership includes key support by local partners in target urban markets, including TechTown Detroit, its city's most established business accelerator and incubator, which also operates a hyper-local economic development program, SWOT City, in Detroit's historically underserved neighborhoods. As a local partner, TechTown will help identify campaign partners and candidates for cooperative membership from within the neighborhoods it serves. "TechTown Detroit is extremely pleased to join Medolac and its partners in supporting this CGI Commitment and looks forward to working with our community stakeholders to maximize the impact experienced in Detroit's neighborhoods," said Leslie Smith, president and CEO. "We immediately recognized this as not only a unique opportunity for wealth creation among inner-city mothers, but also a program that would support the growth and development of our children."
A critical benefit reported by a number of existing Coop members is that the compensation they receive from MMC participation has enabled them to delay their return to work and breastfeed their own infant longer. "By creating a local pathway for urban, African American women to become qualified Mothers Milk Cooperative donors, our CGI Commitment will encourage these mothers to breastfeed longer, provide community peer support for breastfeeding and create new income opportunities for these women and their families," said Elena Medo, Chairman and CEO of Medolac. The company is also actively seeking to broaden the scope of this initiative and add additional alliances in urban centers throughout the United States over the duration of the CGI Commitment.
How the Cooperative Partnership Works:
Responding to the need to increase the supply of donor milk, and with the assistance of a USDA development grant, the Mothers Milk Cooperative was established on Mother's Day of 2013. The MMC and Medolac have been operating the first cooperative producer/processor partnership of its kind in human milk banking and are mutually dedicated to make available the safest and highest quality human donor milk. Breast milk donor candidates are extensively pre-screened; blood is drawn by LabCorp facilities and examined by the American Red Cross National Testing Laboratories, with no upfront cost to donors. If approved, the donor is then provided a milk cooler to be filled with frozen milk that is shipped FedEx overnight free of charge to Medolac's processing facility where it is tested and processed. The commercially sterile, shelf stable donor milk is purchased by hospitals for use with premature infants who might otherwise not have access to human milk.
About the Clinton Global Initiative:
Established in 2005 by President Bill Clinton, the Clinton Global Initiative (CGI), an initiative of the Clinton Foundation, convenes global leaders to create and implement solutions to the world's most pressing challenges. CGI Annual Meetings have brought together more than 180 heads of state, 20 Nobel Prize laureates, and hundreds of leading CEOs, heads of foundations and NGOs, major philanthropists, and members of the media. To date members of the CGI community have made more than 2,900 commitments, which are already improving the lives of more than 430 million people in over 180 countries.
CGI also convenes CGI America, a meeting focused on collaborative solutions to economic recovery in the United States, and CGI University (CGI U), which brings together undergraduate and graduate students to address pressing challenges in their community or around the world. For more information, visit clintonglobalinitiative.org and follow us on Twitter @ClintonGlobal and Facebook at facebook.com/clintonglobalinitiative.
About Medolac Laboratories:
Medolac is committed to ending the global shortage of human donor milk for premature infants in clinical settings. The first commercially sterile human donor milk, with a 3 year shelf life at room temperature, was recently developed by Medolac and is currently being used by hospitals in several U.S. states. The company specializes in innovative, human donor milk products for clinical use, applying proprietary biopharmaceutical processing methods that preserve many of the immune components in human milk. Medolac Laboratories is a Delaware registered corporation headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States. For more information, visit www.medolac.com. For specific press inquiries contact Doug Hawkins, at email@example.com.
Media Contact: Doug Hawkins, Medolac Laboratories, 866-599-7740, firstname.lastname@example.org
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Medolac Laboratories